key: cord-0851544-ia8ki76o
authors: Yap, Ernie; Melaku, Yohannes; Puri, Isha; Ouyang, Jie; Goldwasser, Philip
title: Predicting ionized hypocalcemia: External validation of an ionized calcium prediction model in patients with COVID-19 and renal failure
date: 2022-03-03
journal: Ann Clin Biochem
DOI: 10.1177/00045632211049983
sha: 8dd1465054a2ef6c952fedf0ed9af361ea1a38ef
doc_id: 851544
cord_uid: ia8ki76o

BACKGROUND: Ionized hypocalcemia is common in critically ill patients with COVID-19 and is associated with adverse outcomes. We previously developed a linear model that estimates ionized calcium (I(Ca)) by adjusting total calcium (T(Ca)) for the three components of the anion gap and albumin. On internal validation, it outperformed the popular method that corrects T(Ca) for albumin alone (cT(Ca)) in diagnosing low I(Ca). In this study, we sought to externally validate our I(Ca) model in hospitalized COVID-19 positive patients. METHODS: We retrospectively studied all 200 patients with COVID-19 who were admitted to the State University of New York Downstate Medical Center between March 11(th) and April 30(th) 2020 and referred to the nephrology service for renal failure, and who had I(Ca) measured on a venous blood gas within 25 min of a comprehensive metabolic panel. We compared the performance of the I(Ca) model and cT(Ca) in diagnosing low I(Ca) by ROC analysis, and also examined the accuracy of the absolute values predicted by the two methods relative to measured I(Ca). RESULTS: On ROC analysis, the I(Ca) model was better than cT(Ca) (area under ROC curve: 0.872 [0.025] vs. 0.835 [0.028]; p = 0.045). The I(Ca) model estimated I(Ca) accurately, but the cT(Ca) method seemed to overcorrect T(Ca,) as a substantial number of patients with clearly normal cT(Ca) values had low I(Ca). CONCLUSIONS: In an external validation cohort, the I(Ca) model estimated I(Ca) accurately and was better than cT(Ca) in the diagnosis of low I(Ca). This finding can be useful in guiding direct I(Ca) testing.

New York City was the epicenter of the COVID-19 pandemic, affecting more than 3400 persons per 100,000 in the borough of Brooklyn alone. 1 Many people were critically ill with multiorgan system involvement and required intensive care. Low ionized calcium (I Ca ) is a common abnormality among critically ill COVID-19 patients and has been found to be an important predictor of COVID-19 positivity at triage and of a poor outcome in infected patients, in analyses that accounted for pH and other covariates. [2] [3] [4] Although low I Ca can be diagnosed with the ion-selective electrodes available on blood gas analyzers and other point-of-care analyzers, direct measurement is still not routine, because of its cost, labor and sample requirements, [5] [6] [7] [8] and the ferocity of the pandemic has further strained hospital resources. As a result, it is still common clinical practice to infer the presence of an abnormal I Ca indirectly, using an equation that "corrects" the concentration of total calcium (T Ca ) for that of albumin, with the resultant corrected value (cT Ca ) compared to the reference range for T Ca . 9 The cT Ca equation was popularized in the 1970s, without validation against I Ca . Subsequent external validation studies, which incorporated I Ca , found the diagnostic performance of cT Ca to be poor, 8, [10] [11] [12] but by then its routine use in clinical practice had been cemented. Commonly suggested reasons for the poor performance of cT Ca include its failure to account for alterations in the affinity of albumin for calcium caused by changes in pH and free fatty acids in critical care patients, or for the differences among centers in the albumin assay. 8, [10] [11] [12] [13] [14] Another suggested reason is that cT Ca does not account for variation in the level of small anions that can bind calcium. 13, [15] [16] [17] To account for binding of calcium to small anions and albumin, we recently derived a novel linear regression equation (I Ca model) that estimates I Ca in critical care patients from routine measurements of T Ca , serum albumin, and the three components of the anion gap-sodium (Na), chloride (Cl), and total carbon dioxide (tCO 2 ). 13 In that study, the serum chemistry measurements were made using the Siemens ADVIA Chemistry System 1650 and 1800 analyzers, while I Ca was measured using the Radiometer ABL800 FLEX analyzer. The model's output consists of the most likely arterial I Ca value for a given patient together with a 95% prediction interval (PI), the range that should include the patient's true value 95% of the time. Upon internal validation, the model significantly outperformed cT Ca in detecting low I Ca . Since external validation is essential to demonstrate a model's predictive value, 18 in the present study, we tested the ability of the I Ca model to diagnose low I Ca and to estimate the concentration of I Ca at a different clinical site using a different chemistry analyzer in patients who had closely timed chemistry and venous blood gas (VBG) panels during hospitalization for severe COVID-19 infection, and who, in the course of which, were referred to the nephrology service for renal failure.

In March 2020, the State University of New York (SUNY) Downstate Medical Center was designated as COVID-19only hospital by state directive. 19 We retrospectively collected serum comprehensive metabolic panel and VBG panel results of every COVID-19 positive patient referred to the nephrology service at our center between March 11 th and April 30 th 2020, excluding metabolic panels missing T Ca , albumin, Na, Cl, or tCO 2 and VBGs missing I Ca . The diagnoses for which patients were seen by the nephrology service were either acute kidney injury or pre-existing end stage renal disease (ESRD), with the majority admitted to intensive care. Age and sex were recorded for each patient. In addition, we recorded and paired every metabolic panel with a VBG panel-if the panels were separated by no more than 25 min. Limiting each patient to the single most closely-timed pair of panels, and choosing the earliest pair in case of ties, left 200 pairs, with a mean intra-pair time gap of 0.87 min (range: 0-22 min). The protocol was approved by the institutional review board with a waiver of the need for informed consent (IRB no. 1584306-6).

Serum metabolic panels were performed on the Beckman 

Continuous variables are summarized as the mean and SD and compared using the paired t-test and simple correlation. Hypocalcemia in VBGs was defined as I Ca <1.11 mmol/L, as in our prior study. 13 For each patient, the anion gap was calculated as: Na (mmol/L) -Cl (mmol/L) -tCO 2 (mmol/ L), and cT Ca (mmol/L) was calculated as: T Ca (mmol/L) + 0.02 × [40albumin (g/L)]. 9 I Ca (mmol/L) was estimated by the I Ca model as: 0.219 +0.365 × T Ca -0.0034 × albumin -0.0042 × Na + 0.0073 × Cl + 0.0047 × tCO 2 ; the average 95% PI of this estimate is: ± 0.115 mmol/L (i.e., an average range of 0.23 mmol/L). 13, 20 The I Ca and cT Ca models were examined and compared in two ways. Calibration was assessed by examining their mean predictions relative to the observed mean I Ca values in the entire cohort and in subgroups. Diagnostic discrimination for ionized hypocalcemia was assessed with ROC curves. Since the hypothesis being tested is that the I Ca model would outperform cT Ca in ranking patients for hypocalcemia, the areas under the curves (AUC) and SE were compared using a one-tailed test in accordance with the method of Hanley and McNeil. 21 The Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD) guideline was utilized, 22 and the checklist is available in the Supplement. IBM SPSS Statistics for Windows, Version 24.0 (Armonk, NY: IBM Corp) was used.

The characteristics of the cohort and their biochemical measurements are shown in Table 1 . The mean value of T Ca (2.06 mmol/L) was just above the lower limit of normal (LLN) for T Ca (2.05 mmol/L), while the mean of I Ca (1.10 mmol/L) was well below its LLN (1.15 mmol/L; p < 10 À10 ). Ionized hypocalcemia, defined here as I Ca < 1.11 mmol/L, was present in 96 of 200 patients (48%), and was more common in the patients with ESRD than in the remaining patients (57% versus 42%, p < 0.05). Albumin correlated with T Ca (r = 0.50 p < 10 À13 ), but not with either I Ca (r = À0.07 p = 0.31) or the anion gap (r = 0.016 p = 0.82). I Ca tended to decrease as the anion gap increased (r = À0.21 p = 0.003). The correlation of I Ca with the three "indirect" measures of calcium status was strongest with the I Ca model (r = 0.77 p < 10 À39 ), intermediate with cT Ca (r = 0.71 p < 10 À31 ), and weakest with T Ca (r = 0.58 p < 10 À18 ).

The AUC of the I Ca model was better than that of cT Ca (0.872 [0.025] versus 0.835 [0.028]); p = 0.045; Figure 1 ) and much better than that of T Ca (0.787 [0.032]). The AUC difference remained significant when we compared novel cT Ca and I Ca models derived and internally validated in the present cohort (see Supplemental Results).

There was reasonable agreement between mean I Ca values predicted by the model and those observed across 6 subgroups (Table 2A) was better than the range of model's expected 95% PI (0.23 mmol/L). Table 2B shows the performance of cT Ca with the patients ranked into subgroups identical in size to those of Table 2A . The rates of hypocalcemia observed across the 6 subgroups show, as in the ROC analysis, that ranking by cT Ca was worse than ranking by the I Ca model. A more significant shortcoming of cT Ca , as the overall mean cT Ca of 2.23 (0.18) mmol/L suggests, was its misleading calibration relative to I Ca . For example, the cT Ca values in the third subgroup ranged from 2.19-2.28 mmol/L. Since each value was well above the LLN for T Ca , a negligible risk of hypocalcemia would be expected. However, the mean I Ca in this subgroup was only 1.11 mmol/L, and the rate of hypocalcemia was substantial (45%). This problem is evident in the fourth and sixth cT Ca subgroups too.

Abnormal I Ca is detected poorly by cT Ca , which adjusts T Ca for albumin alone. 8, [10] [11] [12] Since calcium binds to small anions as well as to albumin, the further adjustment of T Ca for the anion gap has been suggested as a possible improvement. 13, [15] [16] [17] We previously derived a model that estimates I Ca by adjusting T Ca for the components of the anion gap and albumin. On internal validation, it was better than cT Ca in the diagnosis of ionized hypocalcemia. 13 In the present study, we confirmed that I Ca varies inversely with the anion gap, and externally validated our I Ca model in a cohort of hospitalized patients with COVID-19 who developed concomitant renal injury or had pre-existing renal disease, conditions in which low I Ca is prevalent and of clinical importance. [2] [3] [4] 8 On ROC analysis, the I Ca model was better than cT Ca in the relative ranking of patients for the diagnosis of hypocalcemia (Figure 1 ). This was also evident by comparing the respective hypocalcemia rate trends observed across subgroups ranked by the I Ca model and by the cT Ca equation (Table 2 ).

In absolute terms, the cT Ca equation appeared to "overcorrect" T Ca by assigning values well above the LLN to several subgroups in Table 3 that proved to have significant rates of ionized hypocalcemia. Since cT Ca values are intended to be judged by the reference range for T Ca , reliance on cT Ca will cause the diagnosis to be entirely overlooked in those patients. This poor alignment of cT Ca with I Ca could be the result of the absence of critically ill patients in the cT Ca equation's original derivation cohort, or calibration differences between the original and the local laboratories, and it could hypothetically be mitigated by introducing a variety of local center corrections, with the simplest being a fixed reduction to cT Ca of, for example, 0.17 mmol/L (equivalent to changing the reference value of albumin used in the cT Ca equation from 40 g/L to the current cohort's mean of 31.6 g/ L). 14, 23 It is noteworthy that the I Ca model required no such local correction in this external validation study. It provided accurate absolute estimates of mean I Ca within the cohort overall and its subgroups, with only a small positive bias of approximately 0.02 mmol/L ( Table 2) . A bias of this size is clinically inconsequential, and especially so in respect to the size of the I Ca model's expected 95% PI (±0.115 mmol/L), a degree of imprecision similar to that of a recent canine I Ca model. 17 Such imprecision is inevitable when regression equations are applied to individual patients, with an extreme example being the 95% PI of glomerular filtration rate estimating (eGFR) equations. [24] [25] [26] Consequently, although the I Ca model's estimates are accurate on average, owing to their imprecision, they cannot replace direct I Ca measurement, the gold standard for guiding treatment decisions at the individual patient level. Low I Ca is associated with increased risk in COVID-19, but its measurement is relatively costly. Therefore, we propose that clinicians can more efficiently screen for low I Ca and, in turn, decide when confirmatory I Ca testing is needed by using the I Ca model's point prediction in one of two ways-either by simply comparing it to a cutoff (e.g., <1.15 mmol/L) or by combining it with its 95% PI to define a range (i.e., point prediction ±0.115 mmol/L) that can be used to intuitively assess the likelihood of low I Ca .

Although the I Ca model may not be easy to memorize, its output can be feasibly reported in metabolic panel reports, as is common practice for cT Ca , anion gap, eGFR, and other forms of laboratory-based clinical decision support. Alternatively, the model output could be easily obtained with an internet-based calculator or smartphone app (one is available on the qxmd.com website). 20 The strength of our study is that it tested a prior hypothesis and that the patients studied had COVID-19 and renal failure, conditions in which identification of low I Ca can have a clinical impact. Nonetheless, since most of these patients were critically ill, the application of the I Ca model to less seriously ill patients, such as outpatients with ESRD, cannot be established from the present study, although the model has performed well in such patients in our informal experience. Further validation on other analytic platforms is also warranted. Other limitations of the study include its retrospective data collection, so the possibility that some VBG samples were processed with an excessive delay, potentially resulting in an artifactual fall in pH and reciprocal rise I Ca , 8 cannot be excluded, and that the cohort studied was relatively small and generated by referrals.

In summary, we externally validated our linear I Ca model in a novel laboratory environment by showing that it accurately predicted I Ca and was better than cT Ca in diagnosing ionized hypocalcemia. The point predictions of the model, together with their 95% PI, can be used to help clinicians decide when direct I Ca measurement is needed in individual patients.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) received no financial support for the research, authorship, and/or publication of this article.

The protocol was approved by the SUNY Downstate Health Sciences University Institutional Review Board & Privacy Board with a waiver of the need for informed consent (IRB no. 1584306-6).

Contributorship EY and PG contributed to the study design, statistical analysis, and results interpretation. YM, IP, and JO contributed to data acquisition. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.

Ernie Yap  https://orcid.org/0000-0002-2799-2367

Supplemental material for this article is available online.

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19

Venous blood gas analysis in patients with COVID-19 symptoms in the early assessment of virus positivity

Low levels of total and ionized calcium in blood of COVID-19 patients

When is it appropriate to order an ionized calcium?

Reducing high cost ionized calcium testing

Costs and stewardship of laboratory tests in the capital health district

Ionized calcium: analytical challenges and clinical relevance

Correcting the calcium

Accuracy of methods to estimate ionized and "corrected" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support

Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status

Calcium state estimation by total calcium: the evidence to end the never-ending story

Predicting ionized hypocalcemia in critical care: an improved method based on the anion gap

The impact of the analytical performance specifications of calcium and albumin on adjusted calcium

Improved method for calculating calcium fractions in plasma: reference values and effect of menopause

A calculation model for serum ionized calcium based on an equilibrium equation for complexation

Development of a multivariate predictive model to estimate ionized calcium concentration from serum biochemical profile results in dogs

Risk prediction models: II. External validation, model updating, and impact assessment

Cuomo designates university hospital of Brooklyn as a COVID-19 only facility

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement

Calcium -An adjustment too far or not far enough?

Calculating confidence intervals for regression and correlation

Prediction interval analysis is underutilized and can be more helpful than just confidence interval analysis

Race and the false precision of glomerular filtration rate estimates